Home › Lung Cancer › California › Fullerton
Lung Cancer clinical trials in Fullerton, CA
4 studies for Lung Cancer are looking for participants at sites in and around Fullerton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
- Providence St. Jude Medical Center, Fullerton
- and 1 more
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
Recruiting
- UCI Health - Yorba Linda, Yorba Linda · 7 mi away
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RecruitingPhase 3
- St. Jude Medical Center, Fullerton
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
- St Jude Heritage Medical Group, Fullerton
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Arlington, VA41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Fullerton
- Non-Small Cell Lung Cancer13 studies
- Breast Cancer9 studies
- Ovarian Cancer6 studies
- Cancer (all types)5 studies
- Lupus5 studies
- Pancreatic Cancer4 studies
- Colorectal Cancer3 studies
- Melanoma3 studies
- Stomach Cancer3 studies
- Esophageal Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Macular Degeneration3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.